Ciphergen Reports Biomarkers Of Alzheimer's Disease

Ciphergen
Biosystems, Inc. (Nasdaq: CIPH) announced today results of a multi-site
study aimed at discovering and validating biomarkers for Alzheimer's
disease. For biomarker discovery, cerebrospinal fluid (CSF) samples were
analyzed from 65 Alzheimer's disease patients and 44 controls. Thirty peaks
were identified with p